ADAR1-MEDIATED RNA EDITING IN RESISTANCE TO HYPOMETHYLATING AGENTS (HMA) IN HIGH-RISK MYELODYSPLASTIC SYNDROMES (HR-MDS)

EHA Library, Ioannis Kotsianidis, 4160680

PROGNOSTIC SCORE MODELING FOR ADULT PATIENTS WITH PHILADELPHIA CHROMOSSOME-NEGATIVE ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Eduardo Chapchap, 4160456

COMPARATIVE EFFICACY OF THE GIMEMA LAL1913 STANDARD CHEMOTHERAPY PROTOCOL VERSUS THE STANDARD ARM OF THE E1910 TRIAL IN MRD-NEGATIVE PH-NEGATIVE ALL: A MAIC ANALYSIS

EHA Library, Alfonso Piciocchi, 4160455

MULTICENTER REAL-WORLD STUDY ON INOTUZUMAB AS A BRIDGE TO CELLULAR THERAPY IN RELAPSED/REFRACTORY B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Alicia Aguirre, 4160453

PEGASPARGASE ADMINISTRATION IN ACUTE LYMPHOBLASTIC LEUKEMIA PATIENTS AGED 55 YEARS OR OLDER TREATED WITH THE PEDIATRIC-INSPIRED PROGRAM LAL1913. A SUBANALYSIS OF THE CAMPUS ALL STUDY

EHA Library, Davide Lazzarotto, 4160452

A RETROSPECTIVE STUDY OF RECIPIENT-DERIVED VERSUS DONOR-DERIVED CAR-T CELL THERAPY IN RELAPSED B-ALL PATIENTS AFTER TRANSPLANTATION

EHA Library, Lichao Liu, 4160451

HIGH IL7R DEFINES FAVORABLE T-ALL PROGNOSIS: CROSS-VALIDATION IN PEDIATRIC COHORTS

EHA Library, Senlin Zhang, 4160450

MUTATIONS IN GENES ASSOCIATED WITH CLONAL HEMATOPOIESIS IN PATIENTS WITH ACUTE T-CELL LYMPHOBLASTIC LEUKEMIA/LYMPHOMA

EHA Library, Anastasia Vasilieva, 4160449

INOTUZUMAB OZOGAMICIN IN PEDIATRIC CD22-POSITIVE VERY HIGH RISK FIRST RELAPSE B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA: PRELIMINARY RESULTS OF THE ITCC-059 STUDY

EHA Library, Erica Brivio, 4160447

LEUKEMIC STEM CELL SIGNATURES IMPROVE RISK STRATIFICATION IN T-ALL PATIENTS

EHA Library, YI WEI Lee, 4160446

B-PRECURSOR ACUTE LYMPHOBLASTIC LEUKAEMIA CAUSES PARACRINE SENESCENCE IN MESENCHYMAL STROMAL CELLS TO SUBVERT THE TREATMENT RESPONSE IN ADULT ACUTE LYMPHOBLASTIC LEUKAEMIA

EHA Library, Aditi Dey, 4160442

IDENTIFYING SYNERGISTIC ACTIVITIES OF COMBINED INHIBITION OF TYROSINE KINASES AND ANTI-APOPTOTIC MOLECULES IN ABL1 FUSION-POSITIVE ALL

EHA Library, Johanna Bender, 4160439

WHOLE TRANSCRIPTOME SEQUENCING UNCOVERS KEY CODING AND NON-CODING BIOMARKERS IN IKZF1PLUS B-ALL

EHA Library, Gadha Krishna Leons, 4160438

THE EXPRESSION AND FUNCTION OF NINJURIN2 IN ACUTE T-LYMPHOID LEUKEMIA

EHA Library, Hongxia Chen, 4160437

MOLECULAR DETERMINANTS OF SENSITIVITY AND RESISTANCE TO A NOVEL AKR1C3-ACTIVATED PRODRUG IN PEDIATRIC LEUKEMIA

EHA Library, Faezeh Khalili, 4160436

MUSASHI-2 PROMOTES CHEMOTHERAPY RESISTANCE OF INFANT KMT2A-REARRANGED ACUTE LYMPHOBLASTIC LEUKEMIA VIA REGULATING THE BIOENERGETIC METABOLISM.

EHA Library, Luigia Valsecchi, 4160435

CHEMORESISTANT ALL CELL LINES EXHIBIT REDUCED MITOCHONDRIAL DAMAGE AND INCREASED MITOCHONDRIAL BIOGENESIS UPON CHEMOTHERAPY.

EHA Library, Jenny Chatzigerou, 4160434

CD49F, A USEFUL MRD AND SUPPOSED PREDICTIVE MARKER OF LATE RELAPSE IN PEDIATRIC B-ALL

EHA Library, Gábor Barna, 4160428

ROLE OF TP53 MUTATIONS IN REFINING PROGNOSIS OF KTM2A-REARRANGED ADULT B-LINEAGE ACUTE LYMPHOBLASTIC LEUKEMIA PATIENTS

EHA Library, Mariangela Di Trani, 4160425

L-ASPARAGINASE ALTERS REDOX HOMEOSTASIS IN ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Matus Kolarik, 4160423

DEEP MOLECULAR PROFILING REVEALS PROGNOSTIC MARKERS FOR REFINED PATIENT STRATIFICATION AND TARGETABLE ALTERATIONS IN PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Borbála Péterffy, 4160420

ANTIBIOTIC-RELATED MICROBIOME DYSBIOSIS DAMPENS HEMATOLOGIC RECOVERY AFTER CD19 CAR-T CELL INFUSION

EHA Library, Jiachen Liu, 4160419

TARGETING POLYAMINES IN PEDIATRIC TCF3::PBX1 B-ALL

EHA Library, James Kim, 4160418

EFFICACY OF NOVEL TARGETED THERAPIES IN DOWN SYNDROME ACUTE LYMPHOBLASTIC LEUKAEMIA

EHA Library, Kunjal Panchal, 4160417

CAPTURE PROFILING REVEALS AGE-RELATED IG/TR PROFILES, MUTATIONAL PATTERNS AND CLONAL HAEMATOPOIESIS SIGNATURES IN ADULT PATIENTS WITH ALL

EHA Library, Cecilia Bozzetti, 4160416

DRUG-RESPONSE MODULATING GENES IN ETV6::RUNX1 CHILDHOOD LEUKEMIA

EHA Library, Laura Oksa, 4160415

H3K4 TRIMETHYLATION IS A TARGETABLE DEPENDENCY IN T-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA (T-ALL)

EHA Library, Gabriela Segat, 4160406

AGE-DEPENDENT TUMOUR-IMMUNE INTERACTIONS GOVERNS IMMUNOTHERAPY RESPONSES IN LEUKAEMIA AND OTHER PAEDIATRIC CANCERS

EHA Library, Sebastien Malinge, 4160409

DISCOVERY OF A NOVEL BCP-ALL MOLECULAR SUBGROUP DEFINED BY IGH::FENDRR GENE FUSION, FOXF1 OVEREXPRESSION AND KRAS A146 MUTATION

EHA Library, Sonja Bendig, 4160412

DNMT3A LIMITS MYELOID SIGNALING RESPONSES IN T-CELL PROGENITORS DURING NORMAL AND LEUKEMIC DEVELOPMENT

EHA Library, Marissa Foo, 4160413

SENSITISATION AND ERADICATION OF DRUG-RESISTANT PAEDIATRIC ETP-ALL BY REPURPOSING DECITABINE

EHA Library, Yizhou Huang, 4160422

CLUSTERING ANALYSIS OF ALTERNATIVE SPLICING IN B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA IDENTIFIED TARGETABLE SUBTYPE WITH GLOBAL SPLICING DEFECTS

EHA Library, Margaret Heung-Ling Ng, 4160424

NOTCH1 TRANSLOCATIONS DEFINE A SPECIFIC SUBTYPE OF HIGH-RISK CORTICAL TYPE T-CELL LYMPHOBLASTIC LEUKEMIA/LYMPHOMA

EHA Library, Martina Lucarelli, 4160426

SMARCC1 CONTROLS THE ONCOGENIC NOTCH1 TRANSCRIPTIONAL PROGRAM IN T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Khalid Shoumariyeh, 4160427

BCR::ABL1 BALANCES CELLULAR DEMAND AND SUPPLY BY JOINTLY ENGAGING STAT5 SIGNALING AND GLYCOLYTIC METABOLISM DOWNSTREAM OF INTERLEUKIN 7 RECEPTOR IN MURINE PREB CELLS

EHA Library, Dennis Das Gupta, 4160429

TARGETING ONCOGENE-INDUCED SENESCENCE IN ETV6::RUNX1 PRE-LEUKEMIC CELLS

EHA Library, Mayla Bertagna, 4160430

INDUCTION OF ONTOGENY-SPECIFIC PRE-LEUKEMIC STEM CELLS IN A KMT2A::AFF1 MURINE MODEL

EHA Library, Ariana Calderón, 4160431

THERAPEUTIC EFFICACY OF BIOMIMETIC NANODRUG CX4945 IN B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Yan Wang, 4160432

ROLE OF FRUCTOSE TRANSPORTER (GLUT5) EXPRESSION IN B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Serene Xavier, 4160440

LONG NON-CODING RNAS AND THEIR ROLE ON EPIGENOME AS DIAGNOSTIC MARKERS IN CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA OF T CELLS

EHA Library, Giovanni Smaldone, 4160441

EFFICACY AND SAFETY OF REGIMEN WITH OLVEREMBATINIB AND BLINATUMOMAB FOR THE FRONTLINE TREATMENT OF PH-POSITIVE OR PH-LIKE ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Xiuli Xu, 4160443

REAL-WORLD OUTCOMES OF ADULT B-ALL PATIENTS WHO EXPERIENCE RELAPSED OR REFRACTORY DISEASE FOLLOWING BREXUCABTAGENE AUTOLEUCEL, A STUDY BY THE ROCCA CONSORTIUM

EHA Library, Rawan Faramand, 4160444

LONG-TERM OUTCOMES OF PEBL-ENGINEERED CD7 NANOBODY CAR-T (PA3-17 INJECTION) IN RELAPSED/REFRACTORY T-ALL/LBL: PHASE I TRIAL UPDATE

EHA Library, Meng Lv, 4160445

COMBINATION OF OLVEREMBATINIB AND VP REGIMEN AS FIRST-LINE THERAPY FOR ADULT PATIENTS WITH PHILADELPHIA CHROMOSOME-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA: A SINGLE-ARM, MULTICENTRE, PHASE 2 TRIAL

EHA Library, Gaixiang Xu, 4160448

CLINICAL EFFICACY ANALYSIS OF CAR-T THERAPY IN PATIENTS WITH RELAPSED/REFRACTORY B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA WITH EXTRAMEDULLARY DISEASE

EHA Library, Zhao defeng, 4160454

RELAPSE RISK AND OUTCOME OF DISCONTINUING ASPARAGINASE IN CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, xingchen wang, 4160457

CREB-BINDING PROTEIN (CBP) DEFICIENCY IN THE EARLY B CELL COMPARTMENT IMPAIRS IMMUNE RESPONSES AND ALTERS GUT MICROBIOME DYNAMICS DURING CHRONIC VIRAL INFECTION

EHA Library, Zhe Lu, 4160414

DIGITAL DROPLET PCR FOR MINIMAL RESIDUAL DISEASE MONITORING IN PHILADELPHIA NEGATIVE ACUTE LYMPHOBLASTIC LEUKEMIA: A REPORT FROM THE PROSPECTIVE NORTHERN ITALY LEUKEMIA GROUP (NILG) ALL 10/07 STUDY

EHA Library, Francesco Ballardini, 4160411

EPIGENETIC DETERMINANTS CONFERRING GLUCOCORTICOID RESISTANCE IN PAEDIATRIC ACUTE LYMPHOBLASTIC LEUKAEMIA

EHA Library, Yashna Walia, 4160410

MAPPING THE AKR1C3 CIS-REGULOME IN ACUTE LYMPHOBLASTIC LEUKEMIA TO ENHANCE TARGETED THERAPY WITH A NEW AKR1C3-ACTIVATED PRODRUG

EHA Library, Hansen Kosasih, 4160408

RESIDUAL DISEASE AND RELAPSE: HOW STOCHASTIC FOUNDER EFFECTS SHAPE PEDIATRIC ALL OUTCOMES

EHA Library, Virginia Turati, 4160407

WHOLE-GENOME SEQUENCING OF 431 PATIENTS REVEALS THE CODING AND NON-CODING MUTATION LANDSCAPES OF PEDIATRIC ACUTE MYELOID LEUKEMIA

EHA Library, Kaito Mimura, 4159199

CLINICO-GENOMIC FEATURES OF THERAPY-RELATED MYELOID NEOPLASMS (T-MNS): A NATIONWIDE STUDY

EHA Library, Carmelo Gurnari, 4159200

HIGH-THROUGHPUT BLOOD-BASED PROTEOMIC PROFILING AND SINGLE CELL ANALYSIS REVEAL STROMAL-DERIVED OSMR AS A NOVEL SOLUBLE BIOMARKER HIGHLY PROGNOSTIC OF AML

EHA Library, Hussein Abbas, 4159201

DEVELOPMENT AND INDEPENDENT VALIDATION OF UNSUPERVISED GENOMIC CLASSIFICATION OF PATIENTS WITH ACUTE MYELOID LEUKEMIA USING HIERARCHICAL DIRICHLET MIXTURE MODELS. A HARMONY ALLIANCE STUDY

EHA Library, Amin Turki, 4159225

EARLY RESPONSE PREDICTION BY SINGLE CELL IMMUNE AND SIGNALING PROFILING IN CHRONIC MYELOID LEUKEMIA

EHA Library, Stein-Erik Gullaksen, 4159237

COMPREHENSIVE MOLECULAR CHARACTERIZATION OF TREATMENT-FREE REMISSION AND RELAPSE IN CML PATIENTS: THE EURO-SKI BIOMARKER STUDY

EHA Library, Sebastien Rinaldetti, 4159241

TAFASITAMAB (TAFA) PLUS LENALIDOMIDE (LEN) AND RITUXIMAB (R) FOR PATIENTS WITH RELAPSED OR REFRACTORY FOLLICULAR LYMPHOMA (R/R FL): RESULTS FROM THE PHASE 3 INMIND STUDY

EHA Library, Marek Trneny, 4159307

EFFICACY OF RITUXIMAB-BENDAMUSTINE WITH OR WITHOUT ACALABRUTINIB IN PATIENTS WITH UNTREATED, HIGH-RISK MANTLE CELL LYMPHOMA: AN ANALYSIS OF THE PHASE 3 ECHO TRIAL

EHA Library, Martin Dreyling, 4159310

COMBINATION TREATMENT WITH NOVEL BCL2 INHIBITOR SONROTOCLAX (BGB-11417) AND ZANUBRUTINIB INDUCES HIGH RATE OF COMPLETE REMISSION FOR PATIENTS WITH RELAPSED/REFRACTORY MANTLE CELL LYMPHOMA

EHA Library, Raul Cordoba, 4159311

REAL-WORLD-EVIDENCE IN THE ERA OF EBMT CRITERIA FOR PEDIATRIC SINUSOIDAL OBSTRUCTION SYNDROME AND TREATMENT WITH DEFIBROTIDE: A REPORT FROM JAPANESE NATIONWIDE SURVEY

EHA Library, Hirotoshi Sakaguchi, 4159342

MYELOABLATIVE FRACTIONATED BUSULFAN CONDITIONING REGIMEN WITH SORAFENIB FOR ALLOGENEIC STEM CELL TRANSPLANT IN PATIENTS WITH AML: RESULTS OF A PHASE 1/2 CLINICAL TRIAL

EHA Library, Uday Popat, 4159343

ALLOGENIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN AML PATIENTS TREATED WITH AZACITIDINE AND VENETOCLAX : A RETROSPECTIVE MULTICENTER REAL-LIFE STUDY BY FRENCH AURAML GROUP

EHA Library, Urbain Tauveron-Jalenques, 4159344

IMPACT OF HYPOMETHYLATING AGENTS +/- VENETOCLAX FOR THE MANAGEMENT OF ACUTE MYELOID LEUKEMIA AND MYELODYSPLASTIC PATIENTS RELAPSING AFTER ALLOGENEIC STEM CELL TRANSPLANTATION: A SUBANALYSIS ON 308 PATIENTS OF THE GITMO AML/MDS-RELAPSE REGISTRY STUDY.

EHA Library, Michele Malagola, 4159345

RAVULIZUMAB PLUS BEST SUPPORTIVE CARE TO TREAT PEDIATRIC PATIENTS WITH HEMATOPOIETIC STEM CELL TRANSPLANTATION-ASSOCIATED THROMBOTIC MICROANGIOPATHY: FIRST RESULTS FROM A PHASE 3 TRIAL

EHA Library, Michelle Schoettler, 4159346

OUTCOMES OF PERIPHERAL BLOOD STEM CELLS VERSUS BONE MARROW IN ADULT SICKLE CELL DISEASE PATIENTS UNDERGOING HAPLOIDENTICAL ALLOGENEIC STEM CELL TRANSPLANTATION

EHA Library, Maud Zwolsman, 4159362

THE IMPACT OF ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION ON SICKLE CELL RETINOPATHY AND MACULOPATHY: A PROSPECTIVE, OBSERVATIONAL STUDY

EHA Library, Elisabeth Dovern, 4159365

HYDROXYUREA IMPROVES MESENTERIC BLOOD FLOW AND REDUCES GUT PERMEABILITY IN SICKLE CELL DISEASE MICE

EHA Library, Erica Gotardo Azevedo, 4159366

BURNOUT SYMPTOMS AMONG HEMATOLOGY PROFESSIONALS: AN EHA SURVEY

EHA Library, Côme Bommier, 4159402

PRECISION MEDICINE FOR RELAPSED/REFRACTORY T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA : A FRENCH ALL-TARGET OBSERVATORY REPORT

EHA Library, Aurélie Cabannes-Hamy, 4159186

CHROMATIN HUBS REGULATE CELL IDENTITY AND ONCOGENIC CIRCUITS IN PEDIATRIC T CELL LEUKEMIA

EHA Library, Francesco Boccalatte, 4159183

ACQUISITION OF AN IMMUNOSUPPRESSIVE MICROENVIRONMENT AFTER CD19 CAR T CELL TREATMENT IS ASSOCIATED WITH T-CELL DYSFUNCTION AND RESISTANCE IN B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Chiara F Magnani, 4159182

MULTIOMIC AND SINGLE CELL RNA-ANALYSES REVEAL TREATMENT RESISTANT STEM-LIKE CELLS TO DRIVE RELAPSE OF PEDIATRIC T-LYMPHOBLASTIC LEUKEMIA (T-ALL)

EHA Library, Kerstin Rauwolf, 4159184

A GENE EXPRESSION BASED MACHINE LEARNING CLASSIFIER ROBUSTLY IDENTIFIES 20 T-ALL SUBTYPES ACROSS COHORTS AND AGE GROUPS.

EHA Library, Thomas Beder, 4159185

ASSOCIATION BETWEEN SOCIO-ECONOMIC INEQUALITIES AND HEALTH-RELATED QUALITY OF LIFE OF PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA: ANALYSIS FROM THE GIMEMA-CLARITY STUDY

EHA Library, Francesco Sparano, 4159406

ASSESSMENT OF THE IMPACT OF DEMOGRAPHICS, INFORMATION PROVISION, AND INVOLVEMENT IN TREATMENT DECISION ON LEUKAEMIA PATIENTS' QUALITY OF LIFE: PRIMARY ANALYSIS OF GLOBAL STUDY DATA

EHA Library, Samantha Nier, 4159405

METHYLPHENIDATE ALLEVIATES FATIGUE IN HAEMATOLOGICAL CANCER: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, CROSSOVER TRIAL - THE MICRO TRIAL

EHA Library, Henrik Frederiksen, 4159404

INVESTIGATING GLOBAL GENDER DEMOGRAPHICS AND EQUITY AMONG HEMATOLOGISTS

EHA Library, Florence Broussais Guillaumot, 4159403

SMALL ACTIVATING RNA-MEDIATED INDUCTION OF HBG VIA LIPOSOME DELIVERY FOR IN VIVO TREATMENT OF SICKLE CELL DISEASE

EHA Library, Bríd Ryan, 4159364

HIGH MORTALITY DUE TO PNEUMOCOCCAL MENINGITIS IN CHILDREN WITH SICKLE CELL DISEASE: A FRENCH MULTICENTER OBSERVATIONAL STUDY FROM 2001 TO 2021.

EHA Library, Inès FAFI, 4159363

MORNINGSUN: OPEN-LABEL PHASE II TRIAL OF THE EFFICACY AND SAFETY OF SUBCUTANEOUS MOSUNETUZUMAB (MOSUN SC) AS FRONTLINE (1L) TREATMENT IN SYMPTOMATIC PATIENTS WITH MARGINAL ZONE LYMPHOMA (MZL)

EHA Library, John M. Burke, 4159309

UPDATED EFFICACY & SAFETY OF THE BRUTON TYROSINE KINASE (BTK) DEGRADER BGB-16673 IN PATIENTS WITH RELAPSED/REFRACTORY WALDENSTRÖM MACROGLOBULINEMIA (WM): ONGOING PHASE (PH) 1 CADANCE-101 STUDY RESULTS

EHA Library, Anna Maria Frustaci, 4159308

DARATUMUMAB OR OBSERVATION FOR MINIMAL RESIDUAL DISEASE REAPPERANCE IN MULTIPLE MYELOMA: RESULTS FROM THE PREDATOR-MRD RANDOMIZED TRIAL

EHA Library, Krzysztof Jamroziak, 4159281

ISATUXIMAB SUBCUTANEOUS VIA AN ON-BODY DELIVERY SYSTEM VERSUS ISATUXIMAB INTRAVENOUS, PLUS POMALIDOMIDE AND DEXAMETHASONE, IN RELAPSED/REFRACTORY MULTIPLE MYELOMA: THE RANDOMIZED PHASE 3 IRAKLIA STUDY

EHA Library, Xavier Leleu, 4159280

LINVOSELTAMAB + CARFILZOMIB IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA: INITIAL RESULTS FROM THE LINKER-MM2 TRIAL

EHA Library, Salomon Manier, 4159279

PHASE 2 REGISTRATIONAL STUDY OF ANITOCABTAGENE AUTOLEUCEL FOR RELAPSED AND/OR REFRACTORY MULTIPLE MYELOMA (RRMM): UPDATED RESULTS FROM IMMAGINE-1

EHA Library, Gurbakhash Kaur, 4159278

TALQUETAMAB + CETRELIMAB IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA: INITIAL SAFETY AND EFFICACY RESULTS FROM THE PHASE 1B TRIMM-3 STUDY

EHA Library, Aurore Perrot, 4159277

SETD2 DEFICIENCY IN CML INDUCES METABOLIC REPROGRAMMING CONTRIBUTING TO DRUG RESISTANCE AND DISEASE PROGRESSION

EHA Library, Manuela Mancini, 4159240

INTEGRATING GENOMIC AND TRANSCRIPTOMIC INSIGHTS FOR PREDICTING RESPONSES AND OUTCOMES IN PATIENTS WITH CML RECEIVING 3RD-GENERATION TKI THERAPY

EHA Library, Xiaoshuai Zhang, 4159239

IMPACT OF MITOCHONDRIAL DNA MUTATIONS ON METABOLIC ADAPTATION AND TYROSINE KINASE INHIBITOR RESPONSE IN CHRONIC MYELOID LEUKAEMIA

EHA Library, Ilaria Stefania Pagani, 4159238

PHASE 3 STUDY OF INTENSIVE CHEMOTHERAPY WITH OR WITHOUT DASATINIB IN PATIENTS WITH CORE-BINDING FACTOR ACUTE MYELOID LEUKEMIA - FINAL ANALYSIS OF THE AMLSG 21-13 TRIAL

EHA Library, Hartmut Döhner, 4159226

REAL WORLD OUTCOMES IN A SERIES OF 417 ADULT PATIENTS WITH KMT2A (MLL) GENE REARRANGED ACUTE MYELOID LEUKEMIA

EHA Library, Irene Navarro-Vicente, 4159224

REFINEMENT OF THE ELN2022 PROGNOSTIC SUBGROUPS IN A REAL-LIFE COHORT OF 1747 INTENSIVELY TREATED ADULT AML PATIENTS OF THE PETHEMA REGISTRY

EHA Library, Joaquín Martinez-Lopez, 4159223

MYELOID NEOPLASMS RISKS FOR GERMLINE DDX41 PATHOGENIC VARIANTS CARRIERS

EHA Library, Marie-Charlotte Villy, 4159222

MULTIMODAL ANALYSIS OF NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA PATIENTS REVEALS ASSOCIATIONS BETWEEN GENETIC LESIONS AND IMMUNOPHENOTYPES

EHA Library, Tim Mocking, 4159198

INTEGRATIVE SPATIAL MULTI-OMICS REVEAL NICHE-SPECIFIC INFLAMMATORY SIGNALING AND DIFFERENTIATION HIERARCHIES IN ACUTE MYELOID LEUKEMIA

EHA Library, Hussein Abbas, 4159197

BLOOD-BASED PROTEOMICS FOR DEEPER INSIGHTS INTO INDOLENT SYSTEMIC MASTOCYTOSIS: THE PIONEER TRIAL EXPERIENCE

EHA Library, Yu-An Kuo, 4171792

A PHASE 3 RANDOMISED TRIAL OF POST-TRANSPLANT CYCLOPHOSPHAMIDE FOR GVHD PROPHYLAXIS IN MATCHED SIBLING DONOR PERIPHERAL BLOOD STEM CELL TRANSPLANTATION: THE ALLG BM12 CAST TRIAL

EHA Library, David Curtis, 4159180

MINOR INDEPENDENT CLONES IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA HAVE A CLL-BIASED BIOLOGICAL SIGNATURE: IMPLICATIONS FOR DISEASE ONTOGENY AND EVOLUTION

EHA Library, Ian Márquez-López, 4159181

BETTER SAFETY AND EFFICACY WITH ROPEGINTERFERON ALFA-2B OVER ANAGRELIDE AS SECOND-LINE TREATMENT OF ESSENTIAL THROMBOCYTHEMIA IN THE TOPLINE RESULTS OF THE RANDOMIZED PHASE 3 SURPASS-ET TRIAL

EHA Library, Harinder Gill, 4159179